BridgeMD
Compares treatment options for Hip Fractures
Official title Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery
ClinicalTrials.gov ID: NCT05660603
What this study is testing
- What it's testing
- Hip fracture (HF) is one of the major worldwide problems that constitute a significant mortality rate, ranging from 14- 36% in the first year after injury, and is associated with profound temporary and sometimes permanent impairment of independence and quality of life in the geriatric population. Surgical treatment is considered the best option for patients with hip fractures,s especially in the elderly, however, it is associated with moderate to severe postoperative pain.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Patient acceptance.
- BMI ≤ 30 kg/m2
- ASA I-III.
- First unilateral surgery for hip fracture including femoral neck, intertrochanteric or subtrochanteric fracture.
- Patient with planned hip fracture surgery within 24-72 hours under general anesthesia.
You likely can't join if
- Multiple trauma, multiple fractures, or pathological fractures
- Prosthetic fracture or usage of bone-cement fixation in the surgery.
- Scheduled for bilateral hip fracture surgery.
- Pre-existing neurological deficit in the lower extremity
- Contraindication for peripheral nerve block (infection at the site of needle insertion, coagulopathy, allergy to local anesthetics used)
- History of chronic pain and taking analgesics
See the full eligibility criteria
- Patient acceptance.
- BMI ≤ 30 kg/m2
- ASA I-III.
- First unilateral surgery for hip fracture including femoral neck, intertrochanteric or subtrochanteric fracture.
- Patient with planned hip fracture surgery within 24-72 hours under general anesthesia.
- Multiple trauma, multiple fractures, or pathological fractures
- Prosthetic fracture or usage of bone-cement fixation in the surgery.
- Scheduled for bilateral hip fracture surgery.
- Pre-existing neurological deficit in the lower extremity
- Contraindication for peripheral nerve block (infection at the site of needle insertion, coagulopathy, allergy to local anesthetics used)
- History of chronic pain and taking analgesics
- History of cognitive dysfunction or mental illness
The study team makes the final eligibility decision.
Where it's taking place
- Zagazig, Alsharqia, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagazig, Alsharqia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.